Russia’s sovereign wealth fund has agreed to supply 25 million doses of its potential Coronavirus vaccine to Egypt via Pharco, which it described as one of the country’s leading pharmaceutical groups.
This comes few weeks after Russian diplomats met with Egyptian officials and the local media to promote the Sputnik V, vaccine developed by Moscow’s Gamaleya Institute. Even though clinical trials have not been completed on the drug, and the Chinese seem to be spearheading the race for an agreement with Egypt
The Russian Direct Investment Fund has struck several deals to supply the Sputnik V vaccine abroad, including 100 million doses to India where it also expects to hold clinical trials.
